Detalhe da pesquisa
1.
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet
; 397(10281): 1276-1292, 2021 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33812487
2.
Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants.
J Infect Dis
; 224(11): 1916-1924, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34009371
3.
Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants.
J Infect Dis
; 222(4): 628-636, 2020 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31681963
4.
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.
N Engl J Med
; 375(18): 1726-1737, 2016 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27806243
5.
Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.
Clin Infect Dis
; 67(11): 1712-1719, 2018 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29590326
6.
Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.
N Engl J Med
; 366(25): 2380-9, 2012 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22716976
7.
Antiretroviral treatment for children with peripartum nevirapine exposure.
N Engl J Med
; 363(16): 1510-20, 2010 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-20942667
8.
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet HIV
; 10(6): e363-e374, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37167996
9.
Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092.
Pediatr Infect Dis J
; 40(5): 446-452, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33464021
10.
Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy.
Pediatr Infect Dis J
; 28(3): 215-9, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19209098
11.
Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus.
J Pediatr Gastroenterol Nutr
; 49(2): 222-32, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19543114
12.
Establishing Dosing Recommendations for Efavirenz in HIV/TB-Coinfected Children Younger Than 3 Years.
J Acquir Immune Defic Syndr
; 81(4): 473-480, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31241542
13.
CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infection.
AIDS
; 31(8): 1129-1136, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28323755
14.
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1.
AIDS Res Hum Retroviruses
; 32(7): 636-47, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26935044
15.
Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in human immunodeficiency virus 1-infected children.
Pediatr Infect Dis J
; 21(7): 653-9, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12237598
16.
A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.
J Acquir Immune Defic Syndr
; 66(4): 399-406, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24815851
17.
A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy.
Vaccine
; 27(43): 6088-94, 2009 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-19450647
18.
Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.
J Infect Dis
; 194(5): 623-32, 2006 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16897661
19.
A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(-3).
J Acquir Immune Defic Syndr
; 32(3): 281-6, 2003 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12626887